Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016

Administered by Department of Veterans' Affairs

Legislation au F2016L00267 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT STATEMENT OF PRINCIPLES CONCERNING

APLASTIC ANAEMIA

NO. 32 OF 2016

 

VETERANS’ ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016.

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(3) and (8) of the Veterans’ Entitlements Act 1986 (the VEA) Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016.

3.             This Instrument amends Statement of Principles concerning aplastic anaemia No. 51 of 2012 by:

  • replacing existing factor (e) in clause 6 concerning 'being exposed to benzene'; and
  • replacing the definition of 'being exposed to benzene' in clause 9 with the definition of 'being exposed to benzene as specified'.

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to the definition of 'being exposed to benzene' in aplastic anaemia in the Government Notices Gazette of 1 September 2015.  This investigation was broadened to benzene and re-advertised in the Government Notices Gazette of 9 December 2015.  Copies of the notices of intention to investigate were circulated to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  Three submissions were received for consideration by the Authority during the investigation.

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation aplastic anaemia as advertised in the Government Notices Gazettes of 1 September 2015 and 9 December 2015.

References

8.             A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 32 of 2016

Kind of Injury, Disease or Death: Aplastic anaemia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors linking particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have aplastic anaemia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes a revised factor which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, aplastic anaemia is connected with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 51 of 2012; and
  • reflects developments in the available sound medical-scientific evidence concerning aplastic anaemia which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016, introduced under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA), was enacted to address the evolving understanding of aplastic anaemia and its connection to service in the Defence Force. The Repatriation Medical Authority determined this instrument to amend the existing Statement of Principles concerning aplastic anaemia No. 51 of 2012, updating the criteria for exposure to benzene, a known risk factor for aplastic anaemia, to better reflect current medical-scientific evidence. The policy objective of this amendment is to facilitate claims for medical treatment and compensation, enhance the review process, and ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby promoting the human rights of veterans, current and former Defence Force members, and their dependents. This legislative instrument, determined pursuant to subsection 196B(8) of the VEA, reflects developments in medical-scientific evidence concerning aplastic anaemia since the previous instrument was established. It specifies the circumstances in which medical treatment and compensation can be extended to eligible persons and is assessed as a technical instrument that improves the medico-scientific quality of outcomes under the VEA and MRCA. The instrument is also compatible with human rights, promoting the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health, ensuring these rights are exercised without discrimination.

Scope and Application

The Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016 applies to veterans and other eligible persons under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This legislative instrument amends the existing Statement of Principles concerning aplastic anaemia No. 51 of 2012 by replacing existing factors and definitions related to exposure to benzene. It aims to facilitate the assessment and determination of claims, ensuring that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby promoting the human rights of veterans and their dependents. The instrument is compatible with the human rights and freedoms recognised in international instruments and does not derogate from any human rights. It specifically enhances the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health for eligible persons. The instrument is a technical measure that reflects the latest medical-scientific evidence and improves the quality of outcomes under the mentioned Acts.

Key Provisions

The main operative sections of this legislation concern the Amendment Statement of Principles concerning aplastic anaemia No. 32 of 2016, which amends the existing Statement of Principles concerning aplastic anaemia No. 51 of 2012 (sections 2 and 3). This amendment primarily involves replacing the existing factor (e) in clause 6 concerning 'being exposed to benzene' and the definition of 'being exposed to benzene' in clause 9 with the definition of 'being exposed to benzene as specified' (section 3). The determination of these principles is made under subsections 196B(3) and (8) of the Veterans’ Entitlements Act 1986 (VEA) (section 2). The instrument also specifies a day of commencement in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003 (section 4). The obligations imposed by this Act on the parties it governs primarily concern the facilitation of claims and assessments under the VEA and the Military Rehabilitation and Compensation Act 2004 (MRCA). It requires the Repatriation Medical Authority (the Authority) to determine the factors linking aplastic anaemia with service based on available sound medical-scientific evidence (section 1). The Authority is mandated to advertise its intention to undertake an investigation and invite submissions from relevant organisations and experts (section 5). The Authority must ensure that the determination of the principles is compatible with human rights and freedoms as recognised in international instruments (section 6). Furthermore, the Act requires the Authority to provide access to the list of references relating to the condition upon request (section 8). Breaches of this Act may not necessarily lead to criminal or civil penalties as the Act primarily deals with the determination of medical-scientific principles and the facilitation of claims. However, non-compliance with the human rights compatibility requirements could lead to scrutiny and potential legal challenges. The Act explicitly states that it is compatible with human rights and does not derogate from any human rights (section 6). The maximum penalties, if any, are not explicitly stated in the provided text but would typically be aligned with general legislative compliance standards, including potential fines or legal sanctions for non-compliance with human rights provisions.

Legal classification tags

Area of Law
Veterans' Law
Human Rights Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Offence Provisions
Consultation Requirements
Human Rights Implications

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.